O. Bueno

发表

MEK1-ERK2 Signaling Pathway Protects Myocardium From Ischemic Injury In Vivo

P. Doevendans, J. Pouysségur, S. Meloche, 2004, Circulation.

c‐Jun N‐terminal kinases (JNK) antagonize cardiac growth through cross‐talk with calcineurin–NFAT signaling

C. Kuan, J. Molkentin, O. Bueno, 2003, The EMBO journal.

Colchicine inhibits GABAA receptors independently of microtubule depolymerization

O. Bueno, N. Leidenheimer, 1998, Neuropharmacology.

Extracellular Signal-Regulated Kinase 2 Interacts with and Is Negatively Regulated by the LIM-Only Protein FHL2 in Cardiomyocytes

R. Schüle, J. Molkentin, O. Bueno, 2004, Molecular and Cellular Biology.

Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo

R. Hajjar, F. del Monte, J. Molkentin, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Targeted Disruption of NFATc3, but Not NFATc4, Reveals an Intrinsic Defect in Calcineurin-Mediated Cardiac Hypertrophic Growth

J. Molkentin, L. D. de Windt, O. Bueno, 2002, Molecular and Cellular Biology.

Impaired cardiac hypertrophic response in Calcineurin Aβ-deficient mice

J. Molkentin, J. Lorenz, O. Bueno, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Altered Skeletal Muscle Phenotypes in Calcineurin Aα and Aβ Gene-Targeted Mice

J. Molkentin, O. Bueno, B. Wilkins, 2003, Molecular and Cellular Biology.

Genetic Loss of Calcineurin Blocks Mechanical Overload-induced Skeletal Muscle Fiber Type Switching but Not Hypertrophy*

J. Neilson, G. Crabtree, K. Yutzey, 2004, Journal of Biological Chemistry.

Altered skeletal muscle phenotypes in calcineurin Aalpha and Abeta gene-targeted mice.

J. Molkentin, O. Bueno, B. Wilkins, 2003, Molecular and cellular biology.

Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death.

J. Molkentin, O. Bueno, 2002, Circulation research.

Targeted Inhibition of p38 Mitogen-activated Protein Kinase Antagonizes Cardiac Injury and Cell Death Following Ischemia-Reperfusion in Vivo*

P. Doevendans, D. Lips, J. Molkentin, 2004, Journal of Biological Chemistry.

Genetic Inhibition or Activation of JNK1/2 Protects the Myocardium from Ischemia-Reperfusion-induced Cell Death in Vivo*

T. Hewett, J. Molkentin, O. Bueno, 2005, Journal of Biological Chemistry.

The Transcription Factor GATA4 Is Activated by Extracellular Signal-Regulated Kinase 1- and 2-Mediated Phosphorylation of Serine 105 in Cardiomyocytes

J. Molkentin, O. Bueno, Q. Liang, 2001, Molecular and Cellular Biology.

The Dual-Specificity Phosphatase MKP-1 Limits the Cardiac Hypertrophic Response In Vitro and In Vivo

J. Molkentin, L. D. de Windt, O. Bueno, 2001, Circulation research.

The Dual-Specificity Phosphatase MKP-1 Limits the Cardiac Hypertrophic Response In Vitro and In Vivo Integrative

J. Molkentin, L. Windt, O. Bueno, 2000 .

Defective T cell development and function in calcineurin A beta -deficient mice.

J. Molkentin, O. Bueno, M. Rothenberg, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Unrestrained p38 MAPK Activation in Dusp1/4 Double-Null Mice Induces Cardiomyopathy

R. Willette, J. Molkentin, J. Lorenz, 2013, Circulation research.

Defective T cell development and function in calcineurin Aβ-deficient mice

J. Molkentin, O. Bueno, M. Rothenberg, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Calcineurin deficiency decreases inflammatory lesions in transforming growth factor β1‐deficient mice

G. Boivin, T. Doetschman, G. Babcock, 2009, Clinical and experimental immunology.

Functional characterization and visualization of a GABAA receptor-GFP chimera expressed in Xenopus oocytes.

L. C. Robinson, O. Bueno, N. Leidenheimer, 1998, Brain research. Molecular brain research.

Calcineurin and hypertrophic heart disease: novel insights and remaining questions.

P. Doevendans, E. van Rooij, J. Molkentin, 2002, Cardiovascular research.

Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy

Jian Xu, J. Molkentin, O. Bueno, 2004, Circulation research.

Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.

Timothy E Hewett, T. Hewett, J. Molkentin, 2003, The Journal of clinical investigation.

DUSP6 (MKP3) Null Mice Show Enhanced ERK1/2 Phosphorylation at Baseline and Increased Myocyte Proliferation in the Heart Affecting Disease Susceptibility*

J. Molkentin, O. Bueno, N. Purcell, 2008, Journal of Biological Chemistry.

The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

R. Kitsis, J. Molkentin, L. D. de Windt, 2000, The EMBO journal.

CONTRIBUTION OF MKP-1 REGULATION OF p38 TO ENDOTOXIN TOLERANCE

H. Wong, J. Molkentin, O. Bueno, 2005, Shock.

APJ ACTS AS A DUAL RECEPTOR IN CARDIAC HYPERTROPHY

E. Ashley, D. Catalucci, R. Bodmer, 2012, Nature.

Calcineurin A &bgr; Gene Targeting Predisposes the Myocardium to Acute Ischemia-Induced Apoptosis and Dysfunction

T. Hewett, P. Doevendans, B. Aronow, 2004, Circulation research.

PKCα regulates the hypertrophic growth of cardiomyocytes through extracellular signal–regulated kinase1/2 (ERK1/2)

J. Molkentin, L. D. de Windt, O. Bueno, 2002, The Journal of cell biology.

Direct and Indirect Interactions between Calcineurin-NFAT and MEK1-Extracellular Signal-Regulated Kinase 1/2 Signaling Pathways Regulate Cardiac Gene Expression and Cellular Growth

J. Molkentin, O. Bueno, B. Wilkins, 2005, Molecular and Cellular Biology.

Activation of Protein Kinase C Induces γ-Aminobutyric Acid Type A Receptor Internalization in Xenopus Oocytes*

L. C. Robinson, O. Bueno, R. Chapell, 1998, The Journal of Biological Chemistry.

Cardiac Hypertrophic Signaling the Good, the Bad and the Ugly

P. Doevendans, E. Rooij, D. Lips, 2002 .

PKCα regulates the hypertrophic growth of cardiomyocytes through extracellular signal–regulated kinase1/2 (ERK1/2)

J. Molkentin, L. D. de Windt, O. Bueno, 2002, The Journal of cell biology.

Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death.

J. Molkentin, O. Bueno, 2002, Circulation research.

05 Inhibition of p38 mitogen-activated protein kinase (MAPK) leads to hypertrophic cardiomyopathy

J. Molkentin, O. Bueno, B. Wilkins, 2002 .

Calcineurin deficiency decreases inflammatory lesions in transforming growth factor β1‐deficient mice

O. Bueno, I. Ormsby, J. Martin, 2009, Clinical and experimental immunology.